Click on the links below to browse our research:

Read more about DrugFactsBoxes on: 

National clinical trials prove that DrugFactsBoxes are effective

Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two randomized trials. Annals of Internal Medicine 2009; 150: 516-527

Communicating data about the benefits and harms of treatment: A randomized trial. Annals of Internal Medicine 2011: 155:87-96.

The Drug Facts Box: Providing Consumers with Simple Tabular Data on Drug Benefit and Harm. Medical Decision Making 2007; 27:655-662.

The Drug Facts Box: Improving Communication of Prescription Drug Information. Proceedings of the National Academy of Sciences, 2013.

The Value of Benefit Data in Direct-to-Consumer Drug Ads. Health Affairs 2004; W4:234-245.                                        

Government organizations recognize DrugFactsBoxes

Minutes of the Risk Communication Advisory Committee, FDA 

Health Product Risk Communication: Is the Message Getting Through? Council of Canadian Academies

The Panel identified drug fact boxes as the most promising innovation in health product risk communication.
FDA should adopt the Drug Facts Box format as its standard.

Problems with drug data today

Lost in transmission—FDA Drug Information that Never Reaches Clinicians. New England Journal of Medicine 2009; 361:1717-1720.

Bringing FDA’s information to market. Arch Intern Med 2009; 169:1985-1987.                                                                                          

How the FDA forgot the evidence: The case of donepezil 23mg. BMJ 2012; 344:e1086.                                                  

Communicating Uncertainties about Prescription Drugs to the Public: A National Randomized Trial. Arch Intern Med 2011; 1717:1463-1468.


Overdiagnosed. Beacon Press; 1st edition (January 3, 2012)

Know Your Chances: Understanding Health Statistics. University of California Press, 2008